Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A112H2 | ISIN: US1488061029 | Ticker-Symbol: N/A
Frankfurt
17.12.24 | 08:00
59,93 Euro
0,00 % 0,00
1-Jahres-Chart  (nicht börsennotiert)
CATALENT INC Chart 1 Jahr

Aktuelle News zur CATALENT

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CATALENT Aktie jetzt für 0€ handeln
DoGenSight Transfers Upstream Phase of LUMEVOQ Manufacturing Process to Catalent2
DoGenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent172Upstream phase of LUMEVOQ manufacturing process successfully transferred Milestone follows successful manufacture of drug product batch to be used for named early access program (AAC) and...
► Artikel lesen
15.05.Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors290Expert appointment further accelerates Prolific's ability to deliver impactful protein production solutions as it prepares to expand its light-controlled bioproduction offerings Prolific Machines...
► Artikel lesen
23.04.Silexion Therapeutics Stock Surges 52% On Catalent Collaboration For Cancer Therapy1
23.04.Silexion Therapeutics Corp: Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities7
15.04.Lisata Therapeutics announces research license with Catalent1
04.02.Ardena Acquires Catalent's Drug Product Manufacturing Facility in Somerset, NJ3
04.02.Ardena Holding NV.: Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America426Ghent, Belgium, 4th February 2025 Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) with facilities...
► Artikel lesen
03.02.Jupiter Neurosciences Partners with Catalent to Produce JOTROL Softgels for Upcoming Clinical Trial4
23.01.Galapagos inks agreement with Catalent for experimental CAR-T therapy26
23.01.Pharmaceutical Technology Excellence Awards 2024: Catalent2
22.01.Catalent backs decentralised manufacture of Galapagos' CAR-T therapy20
21.01.Catalent to Support Galapagos' Decentralized CAR-T Therapy Trials4
16.01.Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus4
30.12.24Catalent, Inc. - 15-12G, Securities registration termination4
18.12.24XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.20241.042The following instruments on Boerse Frankfurt do have their last trading day on 18.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.12.2024ISIN NameJP3802670004 FANCL...
► Artikel lesen
18.12.24Novo Holdings Acquires Catalent In $16.5 Bln Cash Deal566WASHINGTON (dpa-AFX) - Wednesday, Novo Holdings A/S completed the acquisition of Catalent, Inc. (CTLT), a global contract development and manufacturing organization, in an all-cash transaction...
► Artikel lesen
18.12.24Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed775Bagsværd, Denmark, 18 December 2024 - Today, Novo Nordisk completed its acquisition of three manufacturing sites from Novo Holdings A/S. The completion follows the finalisation of Novo Holdings' acquisition...
► Artikel lesen
18.12.24Catalent, Inc.: Novo Holdings Completes Acquisition of Catalent366Catalent to Strengthen its Leading Position as a Global Service Provider for the Pharma and Biotech Industry under Private Ownership Catalent, Inc. ("Catalent"), a leader in enabling the development...
► Artikel lesen
18.12.24Novo Holdings Completes Acquisition of Catalent199SOMERSET, N.J. & COPENHAGEN, Denmark--(BUSINESS WIRE)--Catalent, Inc. ("Catalent"), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings...
► Artikel lesen
Weiter >>
47 Nachrichten in den letzten 12 Monaten